RT Journal Article
SR Electronic
T1 QUEST-AI: A System for Question Generation, Verification, and Refinement using AI for USMLE-Style Exams
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.25.23288588
DO 10.1101/2023.04.25.23288588
A1 Bedi, Suhana
A1 Fleming, Scott L.
A1 Chiang, Chia-Chun
A1 Morse, Keith
A1 Kumar, Aswathi
A1 Patel, Birju
A1 Jindal, Jenelle A.
A1 Davenport, Conor
A1 Yamaguchi, Craig
A1 Shah, Nigam H.
YR 2024
UL http://medrxiv.org/content/early/2024/08/01/2023.04.25.23288588.abstract
AB The United States Medical Licensing Examination (USMLE) is a critical step in assessing the competence of future physicians, yet the process of creating exam questions and study materials is both time-consuming and costly. While Large Language Models (LLMs), such as OpenAI’s GPT-4, have demonstrated proficiency in answering medical exam questions, their potential in generating such questions remains underexplored. This study presents QUEST-AI, a novel system that utilizes LLMs to (1) generate USMLE-style questions, (2) identify and flag incorrect questions, and (3) correct errors in the flagged questions. We evaluated this system’s output by constructing a test set of 50 LLM-generated questions mixed with 50 human-generated questions and conducting a two-part assessment with three physicians and two medical students. The assessors attempted to distinguish between LLM and human-generated questions and evaluated the validity of the LLM-generated content. A majority of exam questions generated by QUEST-AI were deemed valid by a panel of three clinicians, with strong correlations between performance on LLM-generated and human-generated questions. This pioneering application of LLMs in medical education could significantly increase the ease and efficiency of developing USMLE-style medical exam content, offering a cost-effective and accessible alternative for exam preparation.Competing Interest StatementN.H.S. is a cofounder of Prealize Health (a predictive analytics company) and Atropos Health (an on-demand evidence generation company); reports funding from the Gordon and Betty Moore Foundation for developing virtual model deployments; and served on the board of the Coalition for Healthcare AI (CHAI), a consensus-building organization providing guidelines for the responsible use of artificial intelligence in health care. J.A.J. is the founder of Jindal Neurology, Inc. and paid per diem as a physician with Kaiser Permanente, South San Francisco, CA. The other authors declare no competing financial interests. No proprietary NBME data or information were used in the study.Funding StatementThis work is supported by the Mark and Debra Leslie endowment for AI in Healthcare; the Stanford University Department of Medicine; Stanford Healthcare; and the Stanford Medicine Program for AI in Healthcare. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funding bodies.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Stanford University waived ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study will be made available upon reasonable request to the authors https://github.com/som-shahlab/gpt4usmle